| 000 | 00886 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515130316.0 | ||
| 264 | 0 | _c20080919 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1474-4422 | ||
| 024 | 7 |
_a10.1016/S1474-4422(08)70148-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeiner, Howard L | |
| 245 | 0 | 0 |
_aOral laquinimod for treatment of relapsing-remitting multiple sclerosis. _h[electronic resource] |
| 260 |
_bThe Lancet. Neurology _cAug 2008 |
||
| 300 |
_a672-3 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
| 773 | 0 |
_tThe Lancet. Neurology _gvol. 7 _gno. 8 _gp. 672-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(08)70148-0 _zAvailable from publisher's website |
| 999 |
_c18115427 _d18115427 |
||